Multiple Receptor Types Explain Why Growth Hormone Peptides Affect the Heart and Brain
Evidence suggests multiple GHRP receptor subtypes exist — some in the pituitary for GH release, others in the heart and brain for cardiovascular and neurological effects.
Quick Facts
What This Study Found
Multiple GHRP receptor subtypes exist in the pituitary, brain, and heart, with hexarelin binding cardiac tissue — explaining the cardiovascular effects of GH secretagogues beyond their GH-releasing activity.
Key Numbers
How They Did This
Review article synthesizing binding studies, second messenger analyses, and tissue distribution data for GHRP receptors across the hypothalamic-pituitary system, brain, and heart.
Why This Research Matters
Understanding that GHRPs work through multiple receptor subtypes in different tissues helps explain their diverse effects and could lead to more targeted peptide therapies for specific conditions like heart disease or neurological disorders.
The Bigger Picture
GHRPs were designed simply to boost growth hormone, but the discovery of receptors throughout the body has revealed they are part of a much larger signaling system. This eventually led to the discovery of ghrelin and expanded our understanding of metabolic regulation.
What This Study Doesn't Tell Us
Review of preliminary findings from multiple studies. Receptor subtype classification was still evolving. Some binding data was from animal tissues with uncertain human relevance.
Questions This Raises
- ?Can subtype-selective GHRP analogs target specific tissues?
- ?What is the natural ligand for cardiac GHRP receptors?
- ?Do cardiac GHRP receptors mediate cardioprotective effects?
Trust & Context
- Key Stat:
- Receptors in the heart Hexarelin binding to cardiac tissue suggests GHRPs have direct cardiovascular effects independent of growth hormone release
- Evidence Grade:
- Preliminary evidence from a review synthesizing binding studies and second messenger data. Individual findings vary in strength.
- Study Age:
- Published in 1998. The ghrelin receptor was subsequently identified and cloned, confirming many of the receptor subtype predictions made in this review.
- Original Title:
- Binding sites for growth hormone-releasing peptide.
- Published In:
- Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society, 8 Suppl B, 137-40 (1998)
- Authors:
- Ong, H(4), Bodart, V(2), McNicoll, N(3), Lamontagne, D, Bouchard, J F
- Database ID:
- RPEP-00481
Evidence Hierarchy
Summarizes existing research on a topic.
What do these levels mean? →Frequently Asked Questions
Why do GH peptides affect the heart?
GH-releasing peptides were designed to boost growth hormone, but researchers found their receptors also exist in heart tissue. This means they can directly affect the heart independently of growth hormone, potentially offering cardioprotective benefits.
What does multiple receptor subtypes mean?
It means GH peptides can activate different types of receptors in different tissues, producing different effects. A subtype in the pituitary releases GH, while subtypes in the heart or brain may protect those organs or affect behavior.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-00481APA
Ong, H; Bodart, V; McNicoll, N; Lamontagne, D; Bouchard, J F. (1998). Binding sites for growth hormone-releasing peptide.. Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society, 8 Suppl B, 137-40.
MLA
Ong, H, et al. "Binding sites for growth hormone-releasing peptide.." Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society, 1998.
RethinkPeptides
RethinkPeptides Research Database. "Binding sites for growth hormone-releasing peptide." RPEP-00481. Retrieved from https://rethinkpeptides.com/research/ong-1998-binding-sites-for-growth
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.